Received Mar 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 9R2D7 | — |
the administration of Infanrix instead of Tdap to a 47 year old patient; This non-serious case was reported by a nurse via call center representative and described the occurrence of adult use of a child product in a 47-year-old male patient who received DTPa (Infanrix) (batch number 9R2D7, expiry date 23-MAY-2025) for prophylaxis. On 19-FEB-2025, the patient received Infanrix. On 19-FEB-2025, an unknown time after receiving Infanrix, the patient experienced adult use of a child product (Verbatim: the administration of Infanrix instead of Tdap to a 47 year old patient). The outcome of the adult use of a child product was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 20-FEB-2025 A nurse called to report the administration of Infanrix instead of Tdap to a 47 year old patient which led to Adult use of a child product. The health care professional was concerned about expected adverse reactions.